Share Price and Basic Stock Data
Last Updated: November 14, 2025, 11:49 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Diamines & Chemicals Ltd operates in the chemicals sector, focusing on specialty chemicals. The company reported a total revenue of ₹110.34 Cr for the fiscal year ending March 2023, marking a significant increase from ₹65.97 Cr in the previous year. However, revenues are projected to decline to ₹103.97 Cr in FY 2024 and further to ₹71.41 Cr in FY 2025, indicating a volatile revenue trend. Quarterly sales figures reveal fluctuations, with the highest revenue recorded at ₹35.69 Cr in March 2023 and a notable drop to ₹19.92 Cr in September 2023. The revenue from operations per share stood at ₹73.05 for FY 2025, down from ₹113.01 in FY 2023, reflecting a challenging business environment. This inconsistency in revenue generation raises concerns about the company’s ability to maintain stable growth amidst market pressures and competition in the specialty chemicals sector.
Profitability and Efficiency Metrics
Profitability metrics for Diamines & Chemicals Ltd reveal a concerning trend. The net profit for FY 2023 was reported at ₹41.90 Cr, but it is expected to decline to ₹15.47 Cr in FY 2024 and further to ₹2.73 Cr in FY 2025. The operating profit margin (OPM) stood at -32.24% for the latest quarter, a stark contrast to the OPM of 50.41% for FY 2023. This significant drop indicates operational inefficiencies and rising costs that have eroded profitability. The return on equity (ROE) is low at 1.78%, underscoring the challenges in generating adequate returns for shareholders. The interest coverage ratio is robust at 25.34x, indicating that the company can comfortably meet its interest obligations, but the declining net profit raises red flags regarding overall profitability and operational efficiency.
Balance Sheet Strength and Financial Ratios
Diamines & Chemicals Ltd presents a relatively strong balance sheet with total assets amounting to ₹178.09 Cr and total liabilities of ₹162.67 Cr as of March 2025. The company’s reserves have steadily increased to ₹151.47 Cr, reflecting a focus on building a financial cushion. With borrowings standing at a mere ₹0.03 Cr, the company is essentially debt-free, which is a positive indicator of financial health. The current ratio is noted at 7.36, significantly above the typical sector range, suggesting strong liquidity. However, the price-to-book value ratio is at 1.90x, which is above the sector average, indicating that the stock may be overvalued relative to its book value. The return on capital employed (ROCE) is low at 3.33%, suggesting that the company is not efficiently utilizing its capital to generate profits.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Diamines & Chemicals Ltd indicates a strong promoter presence, holding 55.21% of the total shares as of March 2025. This majority stake can instill confidence among investors regarding the management’s commitment to the company’s long-term vision. The public holds 44.77%, with negligible foreign institutional investment (FIIs) at 0.00% and domestic institutional investment (DIIs) at 0.02%, suggesting limited institutional interest. The total number of shareholders stands at 13,363, reflecting a slight decline from previous quarters. The consistent promoter holding indicates a stable governance structure, although the lack of institutional backing may be a concern for potential investors looking for broader market validation. Overall, while the promoter’s strong stake can be a positive sign, the low institutional interest may hinder broader market confidence.
Outlook, Risks, and Final Insight
The outlook for Diamines & Chemicals Ltd appears mixed, with several risks overshadowing its strengths. On the positive side, the company maintains a robust liquidity position with negligible debt, which provides a buffer during challenging market conditions. However, the significant decline in revenue and profitability metrics poses a serious risk to its long-term viability. The volatility in sales and operating margins suggests that the company needs to address operational inefficiencies and rising costs. Additionally, the low ROE and declining net profit projections highlight the need for strategic realignment to enhance shareholder value. In scenarios where the company successfully implements cost-containment measures and improves operational efficiency, it could stabilize its financial performance. Conversely, failure to address these issues may lead to further declines in profitability and investor confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Diamines & Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Diamines & Chemicals Ltd | 284 Cr. | 290 | 566/251 | 158 | 0.34 % | 3.33 % | 1.78 % | 10.0 | |
| Deco-Mica Ltd | 30.2 Cr. | 72.0 | 97.0/56.0 | 13.3 | 64.1 | 0.00 % | 11.8 % | 7.51 % | 10.0 |
| Andhra Sugars Ltd | 1,098 Cr. | 81.0 | 104/64.9 | 13.7 | 121 | 0.99 % | 3.54 % | 2.51 % | 2.00 |
| Tamil Nadu Petro Products Ltd | 990 Cr. | 110 | 130/63.6 | 9.90 | 109 | 1.07 % | 6.97 % | 5.10 % | 10.0 |
| SRF Ltd | 84,736 Cr. | 2,859 | 3,325/2,127 | 52.4 | 447 | 0.25 % | 12.3 % | 10.4 % | 10.0 |
| Industry Average | 14,015.56 Cr | 1,170.63 | 33.62 | 204.28 | 0.39% | 10.57% | 8.89% | 7.60 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23.02 | 26.98 | 24.87 | 35.69 | 31.70 | 19.92 | 23.03 | 29.38 | 16.84 | 19.19 | 17.51 | 17.93 | 12.25 |
| Expenses | 8.33 | 10.61 | 12.75 | 23.32 | 22.11 | 14.93 | 18.31 | 26.00 | 18.20 | 15.58 | 15.99 | 16.24 | 16.20 |
| Operating Profit | 14.69 | 16.37 | 12.12 | 12.37 | 9.59 | 4.99 | 4.72 | 3.38 | -1.36 | 3.61 | 1.52 | 1.69 | -3.95 |
| OPM % | 63.81% | 60.67% | 48.73% | 34.66% | 30.25% | 25.05% | 20.50% | 11.50% | -8.08% | 18.81% | 8.68% | 9.43% | -32.24% |
| Other Income | 0.56 | 0.66 | 0.54 | 0.98 | 0.70 | 0.61 | 0.58 | 0.66 | 0.66 | 0.81 | 0.77 | 0.93 | 1.89 |
| Interest | 0.04 | 0.02 | 0.04 | 0.05 | 0.04 | 0.04 | 0.13 | -0.01 | 0.03 | 0.06 | 0.17 | 0.09 | 0.01 |
| Depreciation | 0.42 | 0.44 | 0.45 | 0.47 | 0.50 | 0.69 | 0.94 | 0.73 | 0.86 | 0.88 | 0.88 | 0.87 | 0.89 |
| Profit before tax | 14.79 | 16.57 | 12.17 | 12.83 | 9.75 | 4.87 | 4.23 | 3.32 | -1.59 | 3.48 | 1.24 | 1.66 | -2.96 |
| Tax % | 25.49% | 25.29% | 26.54% | 25.33% | 28.21% | 23.61% | 30.50% | 33.43% | 6.92% | 27.30% | 34.68% | 20.48% | -7.43% |
| Net Profit | 11.02 | 12.37 | 8.93 | 9.57 | 7.01 | 3.41 | 2.80 | 2.25 | -1.75 | 2.46 | 0.75 | 1.26 | -2.81 |
| EPS in Rs | 11.26 | 12.64 | 9.13 | 9.78 | 7.17 | 3.49 | 2.86 | 2.30 | -1.79 | 2.51 | 0.77 | 1.29 | -2.87 |
Last Updated: August 19, 2025, 8:00 pm
Below is a detailed analysis of the quarterly data for Diamines & Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 12.25 Cr.. The value appears to be declining and may need further review. It has decreased from 17.93 Cr. (Mar 2025) to 12.25 Cr., marking a decrease of 5.68 Cr..
- For Expenses, as of Jun 2025, the value is 16.20 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.24 Cr. (Mar 2025) to 16.20 Cr., marking a decrease of 0.04 Cr..
- For Operating Profit, as of Jun 2025, the value is -3.95 Cr.. The value appears to be declining and may need further review. It has decreased from 1.69 Cr. (Mar 2025) to -3.95 Cr., marking a decrease of 5.64 Cr..
- For OPM %, as of Jun 2025, the value is -32.24%. The value appears to be declining and may need further review. It has decreased from 9.43% (Mar 2025) to -32.24%, marking a decrease of 41.67%.
- For Other Income, as of Jun 2025, the value is 1.89 Cr.. The value appears strong and on an upward trend. It has increased from 0.93 Cr. (Mar 2025) to 1.89 Cr., marking an increase of 0.96 Cr..
- For Interest, as of Jun 2025, the value is 0.01 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.09 Cr. (Mar 2025) to 0.01 Cr., marking a decrease of 0.08 Cr..
- For Depreciation, as of Jun 2025, the value is 0.89 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.87 Cr. (Mar 2025) to 0.89 Cr., marking an increase of 0.02 Cr..
- For Profit before tax, as of Jun 2025, the value is -2.96 Cr.. The value appears to be declining and may need further review. It has decreased from 1.66 Cr. (Mar 2025) to -2.96 Cr., marking a decrease of 4.62 Cr..
- For Tax %, as of Jun 2025, the value is -7.43%. The value appears to be improving (decreasing) as expected. It has decreased from 20.48% (Mar 2025) to -7.43%, marking a decrease of 27.91%.
- For Net Profit, as of Jun 2025, the value is -2.81 Cr.. The value appears to be declining and may need further review. It has decreased from 1.26 Cr. (Mar 2025) to -2.81 Cr., marking a decrease of 4.07 Cr..
- For EPS in Rs, as of Jun 2025, the value is -2.87. The value appears to be declining and may need further review. It has decreased from 1.29 (Mar 2025) to -2.87, marking a decrease of 4.16.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:30 am
| Metric | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 66.86 | 57.40 | 43.94 | 39.09 | 35.58 | 62.82 | 65.97 | 110.34 | 103.97 | 71.41 | 66.88 |
| Expenses | 56.54 | 49.64 | 38.12 | 34.16 | 31.12 | 37.20 | 43.90 | 54.72 | 81.29 | 65.95 | 64.01 |
| Operating Profit | 10.32 | 7.76 | 5.82 | 4.93 | 4.46 | 25.62 | 22.07 | 55.62 | 22.68 | 5.46 | 2.87 |
| OPM % | 15.44% | 13.52% | 13.25% | 12.61% | 12.54% | 40.78% | 33.45% | 50.41% | 21.81% | 7.65% | 4.29% |
| Other Income | 0.38 | 0.23 | 0.30 | 0.18 | 0.36 | 2.05 | 1.79 | 2.65 | 2.56 | 3.15 | 4.40 |
| Interest | 3.59 | 3.81 | 3.26 | 3.41 | 2.75 | 0.08 | 0.09 | 0.14 | 0.20 | 0.34 | 0.33 |
| Depreciation | 2.16 | 2.39 | 2.43 | 2.03 | 1.99 | 1.79 | 1.67 | 1.78 | 2.85 | 3.49 | 3.52 |
| Profit before tax | 4.95 | 1.79 | 0.43 | -0.33 | 0.08 | 25.80 | 22.10 | 56.35 | 22.19 | 4.78 | 3.42 |
| Tax % | 28.89% | 25.14% | 9.30% | 378.79% | -212.50% | 18.64% | 24.34% | 25.64% | 28.39% | 38.08% | |
| Net Profit | 3.52 | 1.35 | 0.39 | -1.59 | 0.25 | 20.99 | 16.71 | 41.90 | 15.47 | 2.73 | 1.66 |
| EPS in Rs | 3.60 | 1.38 | 0.40 | -1.63 | 0.26 | 21.46 | 17.08 | 42.83 | 15.81 | 2.79 | 1.70 |
| Dividend Payout % | 27.78% | 3.62% | 0.00% | 0.00% | 0.00% | 23.30% | 17.56% | 7.00% | 15.80% | 35.82% |
YoY Net Profit Growth
| Year | 2012-2013 | 2013-2014 | 2014-2015 | 2015-2016 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -61.65% | -71.11% | -507.69% | 115.72% | -20.39% | 150.75% | -63.08% | -82.35% |
| Change in YoY Net Profit Growth (%) | 0.00% | -9.46% | -436.58% | 623.42% | -136.11% | 171.14% | -213.83% | -19.27% |
Diamines & Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2012-2013 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | % |
| 3 Years: | 3% |
| TTM: | -25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | % |
| 3 Years: | -45% |
| TTM: | -75% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | -5% |
| 3 Years: | -8% |
| 1 Year: | -33% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 15% |
| Last Year: | 2% |
Last Updated: September 5, 2025, 3:16 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 56.50 | 65.75 | 67.04 | 72.74 | 75.71 | 54.79 | 55.44 | 75.72 | 58.63 | 70.74 |
| Inventory Days | 177.56 | 122.26 | 184.13 | 184.33 | 155.05 | 283.59 | 43.30 | 233.57 | 135.42 | 335.64 |
| Days Payable | 71.12 | 58.50 | 66.67 | 52.30 | 34.46 | 64.90 | 44.80 | 104.92 | 40.49 | 93.05 |
| Cash Conversion Cycle | 162.95 | 129.52 | 184.50 | 204.77 | 196.31 | 273.47 | 53.93 | 204.37 | 153.56 | 313.33 |
| Working Capital Days | -1.31 | -13.93 | 10.88 | 32.12 | 25.54 | 102.61 | 39.61 | 96.39 | 94.37 | 184.52 |
| ROCE % | 9.89% | 6.86% | 5.77% | 5.61% | 23.96% | 48.22% | 15.78% | 3.33% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 2.79 | 16.24 | 42.84 | 17.08 | 21.46 |
| Diluted EPS (Rs.) | 2.79 | 16.23 | 42.80 | 17.08 | 21.46 |
| Cash EPS (Rs.) | 6.59 | 19.15 | 44.66 | 18.79 | 23.29 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 164.82 | 151.38 | 137.51 | 102.41 | 86.87 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 164.82 | 151.38 | 137.51 | 102.41 | 86.87 |
| Revenue From Operations / Share (Rs.) | 73.05 | 106.33 | 113.01 | 67.57 | 64.21 |
| PBDIT / Share (Rs.) | 8.80 | 25.79 | 59.57 | 24.38 | 28.28 |
| PBIT / Share (Rs.) | 5.23 | 22.88 | 57.75 | 22.67 | 26.45 |
| PBT / Share (Rs.) | 4.88 | 22.68 | 57.60 | 22.59 | 26.38 |
| Net Profit / Share (Rs.) | 3.02 | 16.24 | 42.84 | 17.08 | 21.46 |
| NP After MI And SOA / Share (Rs.) | 2.79 | 15.81 | 42.83 | 17.08 | 21.46 |
| PBDIT Margin (%) | 12.04 | 24.25 | 52.71 | 36.07 | 44.04 |
| PBIT Margin (%) | 7.16 | 21.51 | 51.09 | 33.55 | 41.19 |
| PBT Margin (%) | 6.68 | 21.33 | 50.96 | 33.42 | 41.07 |
| Net Profit Margin (%) | 4.13 | 15.27 | 37.90 | 25.28 | 33.42 |
| NP After MI And SOA Margin (%) | 3.82 | 14.87 | 37.90 | 25.28 | 33.42 |
| Return on Networth / Equity (%) | 1.69 | 10.44 | 31.14 | 16.68 | 24.70 |
| Return on Capital Employeed (%) | 3.08 | 14.69 | 40.81 | 21.30 | 29.10 |
| Return On Assets (%) | 1.53 | 9.51 | 27.73 | 15.11 | 22.15 |
| Asset Turnover Ratio (%) | 0.41 | 0.66 | 0.84 | 0.64 | 0.00 |
| Current Ratio (X) | 7.36 | 7.29 | 5.44 | 8.43 | 9.60 |
| Quick Ratio (X) | 4.76 | 5.61 | 4.11 | 8.07 | 7.46 |
| Inventory Turnover Ratio (X) | 2.92 | 2.17 | 3.48 | 2.58 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 89.57 | 18.97 | 14.00 | 29.26 | 17.41 |
| Dividend Payout Ratio (CP) (%) | 39.30 | 16.01 | 13.43 | 26.61 | 16.05 |
| Earning Retention Ratio (%) | 10.43 | 81.03 | 86.00 | 70.74 | 82.59 |
| Cash Earning Retention Ratio (%) | 60.70 | 83.99 | 86.57 | 73.39 | 83.95 |
| Interest Coverage Ratio (X) | 25.34 | 129.35 | 402.75 | 278.96 | 366.92 |
| Interest Coverage Ratio (Post Tax) (X) | 9.69 | 82.43 | 290.61 | 196.48 | 279.45 |
| Enterprise Value (Cr.) | 265.36 | 454.53 | 366.00 | 225.38 | 226.11 |
| EV / Net Operating Revenue (X) | 3.71 | 4.37 | 3.31 | 3.41 | 3.60 |
| EV / EBITDA (X) | 30.81 | 18.01 | 6.28 | 9.45 | 8.17 |
| MarketCap / Net Operating Revenue (X) | 4.29 | 4.73 | 3.55 | 4.02 | 4.11 |
| Retention Ratios (%) | 10.42 | 81.02 | 85.99 | 70.73 | 82.58 |
| Price / BV (X) | 1.90 | 3.32 | 2.92 | 2.65 | 3.04 |
| Price / Net Operating Revenue (X) | 4.29 | 4.73 | 3.55 | 4.02 | 4.11 |
| EarningsYield | 0.01 | 0.03 | 0.10 | 0.06 | 0.08 |
After reviewing the key financial ratios for Diamines & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 2.79. This value is below the healthy minimum of 5. It has decreased from 16.24 (Mar 24) to 2.79, marking a decrease of 13.45.
- For Diluted EPS (Rs.), as of Mar 25, the value is 2.79. This value is below the healthy minimum of 5. It has decreased from 16.23 (Mar 24) to 2.79, marking a decrease of 13.44.
- For Cash EPS (Rs.), as of Mar 25, the value is 6.59. This value is within the healthy range. It has decreased from 19.15 (Mar 24) to 6.59, marking a decrease of 12.56.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 164.82. It has increased from 151.38 (Mar 24) to 164.82, marking an increase of 13.44.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 164.82. It has increased from 151.38 (Mar 24) to 164.82, marking an increase of 13.44.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 73.05. It has decreased from 106.33 (Mar 24) to 73.05, marking a decrease of 33.28.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 8.80. This value is within the healthy range. It has decreased from 25.79 (Mar 24) to 8.80, marking a decrease of 16.99.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.23. This value is within the healthy range. It has decreased from 22.88 (Mar 24) to 5.23, marking a decrease of 17.65.
- For PBT / Share (Rs.), as of Mar 25, the value is 4.88. This value is within the healthy range. It has decreased from 22.68 (Mar 24) to 4.88, marking a decrease of 17.80.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.02. This value is within the healthy range. It has decreased from 16.24 (Mar 24) to 3.02, marking a decrease of 13.22.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 2.79. This value is within the healthy range. It has decreased from 15.81 (Mar 24) to 2.79, marking a decrease of 13.02.
- For PBDIT Margin (%), as of Mar 25, the value is 12.04. This value is within the healthy range. It has decreased from 24.25 (Mar 24) to 12.04, marking a decrease of 12.21.
- For PBIT Margin (%), as of Mar 25, the value is 7.16. This value is below the healthy minimum of 10. It has decreased from 21.51 (Mar 24) to 7.16, marking a decrease of 14.35.
- For PBT Margin (%), as of Mar 25, the value is 6.68. This value is below the healthy minimum of 10. It has decreased from 21.33 (Mar 24) to 6.68, marking a decrease of 14.65.
- For Net Profit Margin (%), as of Mar 25, the value is 4.13. This value is below the healthy minimum of 5. It has decreased from 15.27 (Mar 24) to 4.13, marking a decrease of 11.14.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.82. This value is below the healthy minimum of 8. It has decreased from 14.87 (Mar 24) to 3.82, marking a decrease of 11.05.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.69. This value is below the healthy minimum of 15. It has decreased from 10.44 (Mar 24) to 1.69, marking a decrease of 8.75.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.08. This value is below the healthy minimum of 10. It has decreased from 14.69 (Mar 24) to 3.08, marking a decrease of 11.61.
- For Return On Assets (%), as of Mar 25, the value is 1.53. This value is below the healthy minimum of 5. It has decreased from 9.51 (Mar 24) to 1.53, marking a decrease of 7.98.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.41. It has decreased from 0.66 (Mar 24) to 0.41, marking a decrease of 0.25.
- For Current Ratio (X), as of Mar 25, the value is 7.36. This value exceeds the healthy maximum of 3. It has increased from 7.29 (Mar 24) to 7.36, marking an increase of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 4.76. This value exceeds the healthy maximum of 2. It has decreased from 5.61 (Mar 24) to 4.76, marking a decrease of 0.85.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.92. This value is below the healthy minimum of 4. It has increased from 2.17 (Mar 24) to 2.92, marking an increase of 0.75.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 89.57. This value exceeds the healthy maximum of 50. It has increased from 18.97 (Mar 24) to 89.57, marking an increase of 70.60.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 39.30. This value is within the healthy range. It has increased from 16.01 (Mar 24) to 39.30, marking an increase of 23.29.
- For Earning Retention Ratio (%), as of Mar 25, the value is 10.43. This value is below the healthy minimum of 40. It has decreased from 81.03 (Mar 24) to 10.43, marking a decrease of 70.60.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 60.70. This value is within the healthy range. It has decreased from 83.99 (Mar 24) to 60.70, marking a decrease of 23.29.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 25.34. This value is within the healthy range. It has decreased from 129.35 (Mar 24) to 25.34, marking a decrease of 104.01.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.69. This value is within the healthy range. It has decreased from 82.43 (Mar 24) to 9.69, marking a decrease of 72.74.
- For Enterprise Value (Cr.), as of Mar 25, the value is 265.36. It has decreased from 454.53 (Mar 24) to 265.36, marking a decrease of 189.17.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.71. This value exceeds the healthy maximum of 3. It has decreased from 4.37 (Mar 24) to 3.71, marking a decrease of 0.66.
- For EV / EBITDA (X), as of Mar 25, the value is 30.81. This value exceeds the healthy maximum of 15. It has increased from 18.01 (Mar 24) to 30.81, marking an increase of 12.80.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.29. This value exceeds the healthy maximum of 3. It has decreased from 4.73 (Mar 24) to 4.29, marking a decrease of 0.44.
- For Retention Ratios (%), as of Mar 25, the value is 10.42. This value is below the healthy minimum of 30. It has decreased from 81.02 (Mar 24) to 10.42, marking a decrease of 70.60.
- For Price / BV (X), as of Mar 25, the value is 1.90. This value is within the healthy range. It has decreased from 3.32 (Mar 24) to 1.90, marking a decrease of 1.42.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.29. This value exceeds the healthy maximum of 3. It has decreased from 4.73 (Mar 24) to 4.29, marking a decrease of 0.44.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.01, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Diamines & Chemicals Ltd:
- Net Profit Margin: 4.13%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.08% (Industry Average ROCE: 10.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.69% (Industry Average ROE: 8.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 9.69
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.76
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 33.62)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.13%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Others | Plot No. 13, PCC Area, Vadodra Gujarat 391350 | info@dacl.co.in http://www.dacl.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Amit Mehta | Executive Chairman |
| Mr. Rajendra Chhabra | Prof.Director |
| Mr. Tanmay Godiawala | Director |
| Mr. Dhruv Mehta | Independent Director |
| Mrs. Kejal Pandya | Independent Director |
| Mr. Priyam Jhaveri | Independent Director |